T0	Outcomes 563 578	serum androgens
T1	Outcomes 1337 1371	levels of intraprostatic androgens
T2	Outcomes 1418 1470	primary end point (dihydrotestosterone/testosterone)
T3	Outcomes 1702 1737	low incidence of complete responses
T4	Outcomes 1742 1766	minimal residual disease
T5	Outcomes 1869 1896	suppresses tissue androgens
T6	Outcomes 1942 1975	intratumoral androgen suppression